1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [a4d45898-aab7-4b39-b12b-9365864ff120] => Array
        (
            [runtime-id] => a4d45898-aab7-4b39-b12b-9365864ff120
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [d28b4af5-d1a2-4088-8f72-cdcb8621a1a0] => Array
                        (
                            [runtime-id] => d28b4af5-d1a2-4088-8f72-cdcb8621a1a0
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;dbffab7c943c4ea285436846000c2a66d5a0b6a7
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [1ee28ed3-c99b-4413-ac3b-92a5de453167] => Array
        (
            [runtime-id] => 1ee28ed3-c99b-4413-ac3b-92a5de453167
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [f5655a0d-fc10-40d6-9c04-43839d1d1ca6] => Array
                        (
                            [runtime-id] => f5655a0d-fc10-40d6-9c04-43839d1d1ca6
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;dbffab7c943c4ea285436846000c2a66d5a0b6a7
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [8b174d7c-df63-4686-847a-5df1918bc673] => Array
        (
            [runtime-id] => 8b174d7c-df63-4686-847a-5df1918bc673
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [8bc3df67-f4b2-4dbc-84ec-6f90e63255a4] => Array
                        (
                            [runtime-id] => 8bc3df67-f4b2-4dbc-84ec-6f90e63255a4
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;dbffab7c943c4ea285436846000c2a66d5a0b6a7
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [a4d45898-aab7-4b39-b12b-9365864ff120] => Array
        (
            [runtime-id] => a4d45898-aab7-4b39-b12b-9365864ff120
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [d28b4af5-d1a2-4088-8f72-cdcb8621a1a0] => Array
                        (
                            [runtime-id] => d28b4af5-d1a2-4088-8f72-cdcb8621a1a0
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;dbffab7c943c4ea285436846000c2a66d5a0b6a7
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [a4d45898-aab7-4b39-b12b-9365864ff120] => Array
        (
            [runtime-id] => a4d45898-aab7-4b39-b12b-9365864ff120
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [d28b4af5-d1a2-4088-8f72-cdcb8621a1a0] => Array
                        (
                            [runtime-id] => d28b4af5-d1a2-4088-8f72-cdcb8621a1a0
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;dbffab7c943c4ea285436846000c2a66d5a0b6a7
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [a4d45898-aab7-4b39-b12b-9365864ff120] => Array
        (
            [runtime-id] => a4d45898-aab7-4b39-b12b-9365864ff120
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [d28b4af5-d1a2-4088-8f72-cdcb8621a1a0] => Array
                        (
                            [runtime-id] => d28b4af5-d1a2-4088-8f72-cdcb8621a1a0
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;dbffab7c943c4ea285436846000c2a66d5a0b6a7
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [a4d45898-aab7-4b39-b12b-9365864ff120] => Array
        (
            [runtime-id] => a4d45898-aab7-4b39-b12b-9365864ff120
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [d28b4af5-d1a2-4088-8f72-cdcb8621a1a0] => Array
                        (
                            [runtime-id] => d28b4af5-d1a2-4088-8f72-cdcb8621a1a0
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;dbffab7c943c4ea285436846000c2a66d5a0b6a7
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [d66d0b3d-e001-4e07-89bd-cbe087623da1] => Array
        (
            [runtime-id] => d66d0b3d-e001-4e07-89bd-cbe087623da1
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [2247cc7a-a334-45af-b17c-3d71fd071019] => Array
                        (
                            [runtime-id] => 2247cc7a-a334-45af-b17c-3d71fd071019
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;dbffab7c943c4ea285436846000c2a66d5a0b6a7
                )

        )

)


  
    






















































































    Medicare Coverage of Amyloid PET: Implications for Clinical Practice | American Journal of Neuroradiology  
    



















    

































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
LetterLETTER

  
      

  
      
Medicare Coverage of Amyloid PET: Implications for Clinical Practice
  
    	
J. Ivanidze, A.S. Nordvig, A.R. Fajardo, A.J. Tsiouris, G.C.-Y. Chiang and J.R. Osborne

  
    	
American Journal of Neuroradiology November 2023,  44 (11) E45; DOI: https://doi.org/10.3174/ajnr.A8027 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
On July 17, 2023, the Centers for Medicare & Medicaid Services (CMS) issued a memo proposing to permit Medicare coverage determinations for beta amyloid (Aβ)-targeted PET to be made by Medicare Administrative Contractors. As neuroradiologists, neurologists, and nuclear medicine physicians, we highlight the relevance of this decision to our clinical practice.
Alzheimer disease (AD) is the leading cause of dementia, affecting more than 6 million patients in the United States, with health care costs expected to exceed $1 trillion by 2050.1 Aβ plaques are a widely accepted AD biomarker, as well as a promising therapeutic target, despite recent studies questioning the pathophysiologic significance of Aβ in AD.2
The Imaging Dementia: Evidence for Amyloid Scanning (IDEAS) study enrolled more than 18,000 Medicare beneficiaries 65 years of age or older, aiming to answer 2 central questions: “Does Aβ-targeted PET change management?” and “Does Aβ-targeted PET improve outcomes?”3 While the first question was answered affirmatively, providing the strongest evidence supporting the clinical utility of Aβ-targeted PET to date,3 and evaluation of the second question is ongoing because the IDEAS study had important limitations. Most notably, Black and Hispanic/Latino patients were markedly underrepresented, despite well-documented racial disparities in AD risk, diagnosis, and outcomes.1 The ongoing New IDEAS study seeks to address these disparities by emphasizing an accrual of patients from underrepresented groups.
Recently, Aβ-targeted therapies have been approved by the FDA, including aducanumab and lecanemab. While there are important adverse events to consider, including amyloid-related imaging abnormalities,1 this approval represents the most promising therapeutic option for AD to date, with understandably strong interest from both patients and referring neurologists. Eligibility for Aβ-targeted therapies requires a positive Aβ-targeted PET or CSF analysis. Any emerging and future AD therapies are likely to include Aβ-targeted PET as part of their inclusion criteria. Even as serologic and CSF assays of Aβ show the promise of approximating levels of overall brain Aβ, no other technology allows the assessment of its geographic distribution. Furthermore, Aβ-PET is much preferred to CSF testing from the patients' and caregivers' perspective, due to its noninvasive nature.
Clinicians and scientists at our major academic urban medical center are collaborating closely in studying Aβ-targeted PET in the clinical and research settings, participating in the IDEAS/New IDEAS studies, developing imaging-centered clinical trials evaluating different aspects of AD pathophysiology, and optimizing quantitative analysis methods of Aβ-targeted PET.4 Access to Aβ-PET will improve clinical trial accrual and will increase our understanding of the geographic distribution of brain Aβ levels and how they are affected by emerging disease-modifying therapies. We therefore applaud this decision by CMS to commence reimbursement of Aβ-targeted PET studies in the clinical setting. We further encourage increased training opportunities for practicing radiologists and radiology residents and fellows in the interpretation of Aβ-targeted PET, along with educational opportunities for neurologists and other dementia specialists, and the incorporation of Aβ-targeted PET into national clinical guidelines for imaging of patients with cognitive impairment. It is important for our community to ensure the availability of Aβ-targeted PET, particularly in underserved populations.
Footnotes
References
  1. 1.↵
    2023 Alzheimer's disease facts and figures. Alzheimers Dement 2023;19:1598–695 doi:10.1002/alz.13016 pmid:36918389
    CrossRefPubMed
  2. 2.↵
    1. 

    2. Jack  CR   Jr., 
    3. Bennett  DA, 
    4. Blennow  K, et al
    . NIA-AA Research Framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement 2018;14:535–62 doi:10.1016/j.jalz.2018.02.018 pmid:29653606
    CrossRefPubMed
  3. 3.↵
    1. 

    2. Rabinovici  GD, 
    3. Gatsonis  C, 
    4. Apgar  C, et al
    . Association of amyloid positron emission tomography with subsequent change in clinical management among Medicare beneficiaries with mild cognitive impairment or dementia. JAMA 2019;321:1286–94 doi:10.1001/jama.2019.2000 pmid:30938796
    CrossRefPubMed
  4. 4.↵
    1. 

    2. Smith  NM, 
    3. Ford  JN, 
    4. Haghdel  A, et al
    . Statistical parametric mapping in amyloid positron emission tomography. Front Aging Neurosci 2022;14:849932 doi:10.3389/fnagi.2022.849932 pmid:35547630
    CrossRefPubMed
  


  
  



  
      
  
  

    
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Medicare Coverage of Amyloid PET: Implications for Clinical Practice
  
    	
J. Ivanidze, A.S. Nordvig, A.R. Fajardo, A.J. Tsiouris, G.C.-Y. Chiang, J.R. Osborne

  
    	
American Journal of Neuroradiology Nov 2023, 44 (11) E45; DOI: 10.3174/ajnr.A8027 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    

  

    
 Related Articles
  • No related articles found.
 Cited By...
  • No citing articles found.
 More in this TOC Section
 Similar Articles

  



  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement